asthma, persistent, moderate to severe
DISEASE INTERVENTION COMPARISON RESULTS
N Engl J Med. 2016 Sep;375(9):850-860 Randomized Controlled Trial, Multicenter Study
IN asthma, persistent, moderate to severe The Use of
long-acting beta(2)-agonists, formoterol added to inhaled corticoisteroids, budesonide
As Treatment, Chronic
Is better Than
inhaled corticoisteroids, budesonide alone
To reduce the number of exacerbations (HR 0.8) while not modifying the number of serious asthma-related events (<1%)